News

  • News
    Liberia and Global Fund Deepen Partnership in Building Systems for Health
    26 April 2017
    President Ellen Johnson Sirleaf today outlined strategic areas of partnership between Liberia and the Global Fund, stressing the need to accelerate the process of building resilient and sustainable systems for health to prevent disease outbreaks. Liberia was the epicenter of the 2014 Ebola outbreak that claimed more than 11,000 lives across West Africa.
  • News
    New Global Fund Grant Aims for Malaria Elimination in the Mekong
    25 April 2017
    The Global Fund to Fight AIDS, Tuberculosis and Malaria will continue to support five Southeast Asian countries to expand efforts against malaria, and aim to eliminate the most deadly strain of malaria.
  • News
    Partnership Supports Launch of Malaria Vaccine Pilots in Three African Countries
    24 April 2017
    The world’s first malaria vaccine, RTS,S, has moved a step closer to a global rollout following WHO’s announcement that Ghana, Kenya and Malawi will begin administering the vaccine in 2018.
  • News
    Global Fund Names Rutger de Witt Wijnen Interim General Counsel
    21 April 2017
    The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced that with effect from 1 June 2017, Rutger de Witt Wijnen will become Interim General Counsel at the Global Fund.
  • News
    Global Fund Welcomes Italy’s €140 million Contribution
    07 April 2017
    The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomed a contribution of €140 million from the government of Italy for the three-year period beginning in 2017, a strong demonstration of Italy’s leadership in global health.
  • News
    The Global Fund and Pink Ribbon Red Ribbon Partner to Prevent and Control Cervical Cancer
    06 April 2017
    Today leaders of the Global Fund to Fight AIDS, Tuberculosis and Malaria and Pink Ribbon Red Ribbon signed an agreement to collaborate on programming to prevent cervical cancer. HIV positive women are up to five times more likely to develop cervical cancer, so routine screening and treatment is essential for this population. Screening and treatment for cervical pre-cancer is a cost-effective intervention, costing less than $25 per woman. Pink Ribbon Red Ribbon will work with countries to integrate cervical cancer programming into their HIV/AIDS grants from the Global Fund, building on efforts by national governments and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).